Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | DRD2 | P14416 | 8/20 | 0.49 |
| ▸ | DRD4 | P21917 | 4/20 | 0.49 |
| ▸ | DRD3 | P35462 | 3/20 | 0.49 |
| ▸ | POLB | P06746 | 2/20 | 0.44 |
| ▸ | CACNA1G | O43497 | 4/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | PROKR1 | Q8TCW9 | 1/20 | 0.43 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7961179 | 0.87 | DRD2 (0.47) | ALDH1A1DRD2DRD4DRD3POLB | |
| SCHEMBL7957632 | 0.83 | CCR2 (0.42) | DRD2DRD4DRD3POLBPROKR1 | |
| SCHEMBL7961389 | 0.82 | NPY1R (0.50) | ALDH1A1DRD2DRD4DRD3HSD17B10 | |
| SCHEMBL7949583 | 0.82 | DRD2 (0.54) | ALDH1A1DRD2DRD4DRD3POLB | |
| SCHEMBL7960163 | 0.81 | DRD2 (0.62) | DRD2DRD4DRD3MCHR1 | |
| SCHEMBL7949576 | 0.80 | DRD2 (0.48) | ALDH1A1DRD2DRD4DRD3POLB | |
| SCHEMBL7957585 | 0.79 | KMT2A (0.48) | DRD2POLBCACNA1GHTT | |
| SCHEMBL7964044 | 0.78 | DRD2 (0.53) | ALDH1A1DRD2DRD4DRD3 | |
| SCHEMBL7957652 | 0.76 | DRD2 (0.55) | ALDH1A1DRD2DRD4DRD3POLB | |
| SCHEMBL7964065 | 0.76 | DRD2 (0.53) | DRD2DRD4DRD3MCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6187774-B1 | N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 2001-02-13 | — | — | US | disclosed |
| EP-0885883-A1 | FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF | YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) | 1998-12-23 | — | — | EP | disclosed |